Chemoprevention Efficacy Study in Burkina Faso
NCT05478954
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
800
Enrollment
OTHER
Sponsor class
Conditions
Malaria
Interventions
DRUG:
Sulfadoxine pyrimethamine
DRUG:
Amodiaquine
Sponsor
Malaria Consortium